Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
Joshua J. Joseph, Prakash Deedwania, Tushar Acharya, et al.
Circulation (2022) Vol. 145, Iss. 9
Open Access | Times Cited: 366

Showing 1-25 of 366 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1452
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Chiadi E Ndumele, Janani Rangaswami, Sheryl L. Chow, et al.
Circulation (2023) Vol. 148, Iss. 20, pp. 1606-1635
Open Access | Times Cited: 322
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S68-S96
Open Access | Times Cited: 269
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Chengxu Ma, Xiaoni Ma, Conghui Guan, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 216
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
Chiadi E Ndumele, Ian J. Neeland, Katherine R. Tuttle, et al.
Circulation (2023) Vol. 148, Iss. 20, pp. 1636-1664
Open Access | Times Cited: 193
National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020
Rishav Adhikari, Kunal Jha, Zeina Dardari, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 9
Open Access | Times Cited: 83
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
Péter Ferdinandy, Ioanna Andreadou, Gary F. Baxter, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 159-216
Open Access | Times Cited: 81
Joint association of loneliness and traditional risk factor control and incident cardiovascular disease in diabetes patients
Xuan Wang, Hao Ma, Xiang Li, et al.
European Heart Journal (2023) Vol. 44, Iss. 28, pp. 2583-2591
Open Access | Times Cited: 57
SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis
Celestino Sardu, Maria Consiglia Trotta, Ferdinando Carlo Sasso, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes
Neha J. Pagidipati, Adam J. Nelson, Lisa A. Kaltenbach, et al.
JAMA (2023) Vol. 329, Iss. 15, pp. 1261-1261
Open Access | Times Cited: 53
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020
John W. Ostrominski, Suzanne V. Arnold, Javed Butler, et al.
JAMA Cardiology (2023) Vol. 8, Iss. 11, pp. 1050-1050
Open Access | Times Cited: 49
Machine learning in precision diabetes care and cardiovascular risk prediction
Evangelos K. Oikonomou, Rohan Khera
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, Javed Butler, George L. Bakris, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 2, pp. 108389-108389
Open Access | Times Cited: 39
Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights
George Jia, Hetty Bai, Bethany Mather, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 804-804
Open Access | Times Cited: 33
Combination therapy for kidney disease in people with diabetes mellitus
Daniël H. van Raalte, Petter Bjornstad, David Z.I. Cherney, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 7, pp. 433-446
Closed Access | Times Cited: 26
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999–2018
Binyang Yu, Min Li, Zongliang Yu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
A Novel Early Detection and Prevention of Coronary Heart Disease Framework Using Hybrid Deep Learning Model and Neural Fuzzy Inference System
B. Ramesh, Kuruva Lakshmanna
IEEE Access (2024) Vol. 12, pp. 26683-26695
Open Access | Times Cited: 16
NLRP3 inflammasome-modulated angiogenic function of EPC via PI3K/ Akt/mTOR pathway in diabetic myocardial infarction
Jiapeng Li, Qiu Shu, Guang-Jie Tai, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Shifts in Metabolic Biomarkers Related to Cardiovascular Disease and Diabetes from 2013 to 2023: A Decade of Change, Including the COVID-19 Era
Caishan Fang, Xiangjun Qi, Tianhui Yuan, et al.
Research Square (Research Square) (2025)
Closed Access | Times Cited: 1
Analyzing the impact of glycemic metabolic status on cardiovascular mortality and all-cause mortality related to the estimated glucose disposal rate: a nationwide cohort study
Shiming He, Chao Wang, Xin Huang, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 1
Tirzepatide: A Systematic Update
Imma Forzano, Fahimeh Varzideh, Roberta Avvisato, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14631-14631
Open Access | Times Cited: 46
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
Lee‐Ling Lim, Elaine Chow, Juliana C.N. Chan
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 3, pp. 151-163
Closed Access | Times Cited: 45
Cardiovascular complications in a diabetes prediction model using machine learning: a systematic review
Ooi Ting Kee, Harmiza Harun, Norlaila Mustafa, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 38
Weight loss efficiency and safety of tirzepatide: A Systematic review
Fei Lin, Bin Yu, Baodong Ling, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285197-e0285197
Open Access | Times Cited: 28
Efficacy and safety evaluation of SGLT2i on blood pressure control in patients with type 2 diabetes and hypertension: a new meta-analysis
Qin Zhang, Siyuan Zhou, Lijun Liu
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top